Poland· PL-100107597
Orofar Total Action
A antiseptics product containing benzoxoni chloridum + lidocaini hydrochloridum, registered in Poland by STADA Arzneimittel AG. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Benzoxoni chloridum + lidocaini hydrochloridum is registered in 2 of 19 countries.
Countries holding a registration under ATC R02AA (antiseptics), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Benzoxoni chloridum + lidocaini hydrochloridum · ATC R02AA
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Benzoxoni chloridum + Lidocaini hydrochloridum
- Manufacturer
- STADA Arzneimittel AG
- Country
- Poland (PL)
- ATC code
- R02AA
- ATC class
- Antiseptics
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990933310
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benzoxoni chloridum + lidocaini hydrochloridum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOROFARSTADA Arzneimittel AG, Bad Vilbel
- SwitzerlandMebucaïne Extra Spray, Spray zur Anwendung in der MundhöhleSpirig HealthCare AG
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Benzoxoniumchloride / Lidocaïnehydrochloride Eg (Eurogenerics) Nv, Benzoxoniumchloridlidocainhydrochlorid Eg (Eurogenerics) Nv
- Bulgaria · Орофар
- Czechia · Orofar
- Greece · Orocil Lido®
- Hungary · Mebucain Orange
- Luxembourg · Chlorure De Benzoxonium / Chlorhydrate De Lidocaïne Eg (Eurogenerics) Sa
- Romania · Orofar
- Slovakia · Orofar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cedeb2ab-8987-462e-a5cb-b1824bfbc190 GET /v1/drugs/cedeb2ab-8987-462e-a5cb-b1824bfbc190?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol do stosowania w jamie ustnej",
"source": "urpl",
"strength": "(2 mg + 1,5 mg)/ml",
"packaging": "05909990933310 ¦ OTC ¦ 54751\n1 butelka 30 ml",
"substance": "Benzoxonii chloridum 0.2 g/ml + Lidocaini hydrochloridum 0.15 g/ml",
"common_name": "Benzoxoni chloridum + Lidocaini hydrochloridum",
"pl_product_id": "100107597",
"pozwolenie_nr": "09333",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about benzoxoni chloridum + lidocaini hydrochloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.